Clinical Proof of Concept of OVX836, a single-shot broadly protective Influenza A vaccine for immediate protection against emerging pandemic strains
Award Notice Posted
- Solicitation number
- 75A50125C00008
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Awarded
- to Osivax
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75A50125C00008 Federal contract award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Paris 8 75008 France
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded contract 75A50125C00008 to OSIVAX on July 25, 2025, for $98,593,151.00 to conduct clinical proof of concept studies for OVX836, a single-shot broadly protective Influenza A vaccine. The contract supports development of a vaccine designed to provide immediate protection against emerging pandemic influenza strains, representing a significant investment in pandemic preparedness capabilities. The award notice was posted on October 14, 2025, indicating the contract has already been executed and work is likely underway on this critical public health initiative.
Notice text
Awarded contract 75A50125C00008 to OSIVAX for 98593151.00 on 2025-07-25.
Notice history
5 of 13 notices listed here. See the rest on GovTribe.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response | Office of the Assistant Secretary for Preparedness and Response | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity